CClinicalTrials.gg
Status unknownNCT02941094US_angleUpdated Nov 22, 2016

Insertion Angle and Needle Visualization During Ultrasound Guided Internal Jugular Vein Cannulation

An interventional study of needle PLT-805AT and Ultrasound in Internal Jugular Vein Cannulation, sponsored by Mansoura University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-11-22.

Sponsored by Mansoura University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Nov 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Ultrasound guidance has been established as an effective and safe method during insertion of internal jugular vein catheter.. Needle visualization during advancement toward the vein has a great impact on both safety and success of the procedure. Clinicians have adopted variable techniques to increase needle visualization including changing needle- probe relation (in-plane vs. out-of-plane), or using specific ultrasound needles The angle between the inserting needle and the probe lying on patient skin affects both the distance to the vein and the length of the needle part travelling through the us beam

02

Conditions studied

  • Internal Jugular Vein Cannulation
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • all patients requiring central line insertion

Exclusion criteria

Exclusion Criteria:

  • refusal
  • coagulopathy
  • neck surgeries
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
150 participants (estimated)

Study arms

  • Active comparator
    angle 30 group

    During central line insertion, After choosing the proper position, the skin was infiltrated with %1 lidocaine. The vein will be localized using linear ultrasound probe (PLT-805AT, 8 MHz, Toshiba Tokyo, Japan) attached to ultrasound machine (Xario, Toshiba Tokyo Japan). The needle will be advanced guided by the ultrasound probe with needle skin angle 30-40 degree.

    Device: needle PLT-805AT · Device: Ultrasound

  • Active comparator
    angle 50 group

    During central line insertion,After choosing the proper position, the skin was infiltrated with %1 lidocaine. The vein will be localized using linear ultrasound probe (PLT-805AT, 8 MHz, Toshiba Tokyo, Japan) attached to ultrasound machine (Xario, Toshiba Tokyo Japan). The needle will be advanced guided by the ultrasound probe with needle skin angle 50-60 degree

    Device: needle PLT-805AT · Device: Ultrasound

  • Active comparator
    angle 70 group

    During central line insertion,After choosing the proper position, the skin was infiltrated with %1 lidocaine. The vein will be localized using linear ultrasound probe (PLT-805AT, 8 MHz, Toshiba Tokyo, Japan) attached to ultrasound machine (Xario, Toshiba Tokyo Japan). The needle will be advanced guided by the ultrasound probe with needle skin angle 60-80 degree

    Device: needle PLT-805AT · Device: Ultrasound

Interventions

  • Deviceneedle PLT-805AT

    comparing success rate and complications using different needle to US probe angles.

    Also known as: PLT-805AT, 8 MHz, Toshiba Tokyo, Japan

  • DeviceUltrasound

    Xario, Toshiba Tokyo Japan

06

What researchers measure

Primary outcomes

  1. success rate

    Time frame: 24 hours starting from central line insertion

07

Study locations

1 of 1 sites recruiting
  • Mansoura university
    Mansoura, Dkahleya, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02941094
Lead sponsor
Mansoura University
Responsible party
AlRefaey Kandeel (Dr, Mansoura University) — Principal investigator
First posted
Oct 21, 2016
Start date
Oct 2016
Primary completion
Jun 2017 (estimated)
Completion
Jul 2017 (estimated)
Last update
Nov 22, 2016

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion